Su Z - Search Results

1

An artesunate-modified half-sandwich iridium(iii) complex inhibits colon cancer cell proliferation and metastasis through the STAT3 pathway.

Deng D, Xu N, Wang M, Zhang G, Su Y, Fang H, Su Z. Deng D, et al. Among authors: su z, su y. RSC Chem Biol. 2024 Dec 17. doi: 10.1039/d4cb00114a. Online ahead of print. RSC Chem Biol. 2024. PMID: 39697768 Free PMC article.

2

Cyclometalated iridium(III) complexes as anti-breast cancer and anti-metastasis agents via STAT3 inhibition.

Su Y, Yang J, Wang MM, Fang HB, Liu HK, Yu ZH, Su Z. Su Y, et al. Among authors: su z. J Inorg Biochem. 2024 Feb;251:112427. doi: 10.1016/j.jinorgbio.2023.112427. Epub 2023 Nov 14. J Inorg Biochem. 2024. PMID: 37979498

3

Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition.

Su Y, Tu Y, Lin H, Wang MM, Zhang GD, Yang J, Liu HK, Su Z. Su Y, et al. Among authors: su z. J Inorg Biochem. 2022 Jan;226:111653. doi: 10.1016/j.jinorgbio.2021.111653. Epub 2021 Oct 27. J Inorg Biochem. 2022. PMID: 34740039

4

Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens.

Su Y, Lin H, Tu Y, Wang MM, Zhang GD, Yang J, Liu HK, Su Z. Su Y, et al. Among authors: su z. Chem Sci. 2022 Jan 18;13(5):1428-1439. doi: 10.1039/d1sc06722b. eCollection 2022 Feb 2. Chem Sci. 2022. PMID: 35222927 Free PMC article.

5

Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized α-lipoic acid.

Wang MM, Xue XL, Sheng XX, Su Y, Kong YQ, Qian Y, Bao JC, Su Z, Liu HK. Wang MM, et al. Among authors: su z, su y. RSC Adv. 2020 Feb 3;10(9):5392-5398. doi: 10.1039/c9ra10357k. eCollection 2020 Jan 29. RSC Adv. 2020. PMID: 35498295 Free PMC article.

6

Performance of Ir(III)-Based Anticancer Agents in the Treatment of Cisplatin-Resistant Cancer Cells.

Wang MM, Li HM, Deng DP, Su Y, Su Z. Wang MM, et al. Among authors: su z, su y. ChemMedChem. 2022 Aug 17;17(16):e202200273. doi: 10.1002/cmdc.202200273. Epub 2022 Jul 8. ChemMedChem. 2022. PMID: 35726053

7

Switching the Mode of Cell Death between Apoptosis and Autophagy by Histone Deacetylase 6 Inhibition Levels.

Zhou AM, Wang MM, Su Y, Yu ZH, Liu HK, Su Z. Zhou AM, et al. Among authors: su z, su y. ChemMedChem. 2023 Mar 1;18(5):e202200614. doi: 10.1002/cmdc.202200614. Epub 2023 Jan 18. ChemMedChem. 2023. PMID: 36578101

8

Functional Upgrading of an Organo-Ir(III) Complex to an Organo-Ir(III) Prodrug as a DNA Damage-Responsive Autophagic Inducer for Hypoxic Lung Cancer Therapy.

Wang MM, Deng DP, Zhou AM, Su Y, Yu ZH, Liu HK, Su Z. Wang MM, et al. Among authors: su z, su y. Inorg Chem. 2024 Mar 11;63(10):4758-4769. doi: 10.1021/acs.inorgchem.4c00060. Epub 2024 Feb 26. Inorg Chem. 2024. PMID: 38408314

9

Consolidating Organometallic Complex Ir-CA Empowers Mitochondria-Directed Chemotherapy against Resistant Cancer via Stemness and Metastasis Inhibition.

Yang J, Wang MM, Deng DP, Lin H, Su Y, Shao CX, Li SH, Yu ZH, Liu HK, Su Z. Yang J, et al. Among authors: su z, su y. Inorg Chem. 2024 Mar 18;63(11):5235-5245. doi: 10.1021/acs.inorgchem.4c00321. Epub 2024 Mar 7. Inorg Chem. 2024. PMID: 38452249

10

Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.

Sheng X, Wang MM, Zhang GD, Su Y, Fang HB, Yu ZH, Su Z. Sheng X, et al. Among authors: su z, su y. Bioorg Chem. 2024 Jun;147:107325. doi: 10.1016/j.bioorg.2024.107325. Epub 2024 Apr 2. Bioorg Chem. 2024. PMID: 38583247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,481 results

Search Page

Filters